Skip to main content
$6.34 -$0.07 (-1.1%)

04:00 PM EDT on 10/15/21

Molecular Templates Inc (NASDAQ:MTEM)

CAPS Rating: 1 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Current Price $6.34 Mkt Cap $355.9M
Open $6.50 P/E Ratio 0.00
Prev. Close $6.34 Div. (Yield) $0.00 (0.0%)
Daily Range $6.32 - $6.50 Volume 133,181
52-Wk Range $5.70 - $15.19 Avg. Daily Vol. 360,642

Caps

How do you think NASDAQ:MTEM will perform against the market?

Add Stock to CAPS Watchlist

All Players

97 Outperform
19 Underperform
 

All-Star Players

11 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:MTEM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

topsecret10 (< 20)
Submitted April 01, 2011

Latest direct offering netted company 30 million dollars. Insiders and Institutions have purchased over 5 million shares since early March. Stock Is now about 40 cents under their average buying prices. I love these little biotechs,and I like the… More

zzlangerhans (99.00)
Submitted July 07, 2016

Threshold is now trading well over cash after trading at less than half cash earlier this year. That can only mean one of two things: a leak of impending positive data from phase II trials of tarloxitinib, or momentum trader games. Given what I've… More

NASDAQ:MTEM VS S&P 500 (SPY)

Fools bullish on NASDAQ:MTEM are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about MTEM.

Recs

0
Member Avatar mrbill6 (62.97) Submitted: 9/15/2021 1:46:31 AM : Outperform Start Price: $5.77 NASDAQ:MTEM Score: +9.47

100% growth potential?

Recs

0
Member Avatar smartgainer (< 20) Submitted: 9/27/2016 8:09:25 AM : Outperform Start Price: $13.09 NASDAQ:MTEM Score: -159.84

Clinical trials results for promising cancer drug coming soon.

Recs

0
Member Avatar Ted2400 (< 20) Submitted: 9/2/2016 4:52:37 PM : Outperform Start Price: $13.20 NASDAQ:MTEM Score: -161.34

Market cap is only $80 million. Approval of their lead compound would push this to a billion plus company.

Leaderboard

Find the members with the highest scoring picks in MTEM.

Score Leader

efarev

efarev (41.93) Score: +343.18

The Score Leader is the player with the highest score across all their picks in MTEM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
disquisitor 71.67 5/30/2012 Underperform 3M $79.00 -91.99% +238.39% +330.38 0 Comment
hlacheen 98.70 10/5/2006 Underperform 5Y $30.03 -78.92% +250.25% +329.17 0 Comment
schoolhouserd < 20 1/3/2007 Underperform 1Y $41.80 -84.86% +232.53% +317.39 0 Comment
jsGreenmachine < 20 2/22/2012 Underperform 5Y $59.07 -89.28% +226.85% +316.13 0 Comment
woodsst 74.63 12/22/2006 Underperform 5Y $32.78 -80.69% +233.95% +314.64 0 Comment
bonoway < 20 1/22/2007 Underperform 3M $39.49 -83.97% +230.63% +314.60 0 Comment
mainakn < 20 2/16/2011 Underperform 1Y $34.43 -81.61% +232.93% +314.54 0 Comment
3acrerock 67.30 1/3/2007 Underperform 1Y $37.51 -83.12% +230.59% +313.71 0 Comment
Hotpicks101 28.25 2/9/2012 Underperform 3W $35.75 -82.29% +229.46% +311.75 0 Comment
epocrates < 20 2/2/2007 Underperform 3M $38.28 -83.46% +226.66% +310.12 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MTEM.